HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Daniel F Vatner Selected Research

3- ((3,5- dibromo- 4- (4- hydroxy- 3- (1- methylethyl)phenoxy)phenyl)amino)- 3- oxopropanoic acid

7/2013Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Daniel F Vatner Research Topics

Disease

5Insulin Resistance
01/2015 - 05/2013
2Hyperglycemia
01/2015 - 07/2013
1Hyperlipidemias (Hyperlipidemia)
01/2015
1Dyslipidemias (Dyslipidemia)
01/2015
1Hyperinsulinism (Hyperinsulinemia)
07/2013

Drug/Important Bio-Agent (IBA)

4Non-alcoholic Fatty Liver DiseaseIBA
01/2015 - 05/2013
2Glucose (Dextrose)FDA LinkGeneric
01/2015 - 07/2013
2Insulin (Novolin)FDA Link
01/2015 - 07/2013
1Fatty Acids (Saturated Fatty Acids)IBA
01/2015
1HormonesIBA
01/2015
1ThyroninesIBA
01/2015
1DiiodothyroninesIBA
01/2015
1GC 1 compoundIBA
07/2013
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
07/2013
1Pyruvate CarboxylaseIBA
07/2013
13- ((3,5- dibromo- 4- (4- hydroxy- 3- (1- methylethyl)phenoxy)phenyl)amino)- 3- oxopropanoic acidIBA
07/2013
1Phospholipases (Phospholipase)IBA
05/2013
1Lipase (Acid Lipase)FDA Link
05/2013